Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109,393 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomised comparison of healing response between the BuMA Supreme stent and the XIENCE stent at one-month and two-month follow-up: PIONEER-II OCT randomised controlled trial.
Asano T, Jin Q, Katagiri Y, Kogame N, Takahashi K, Chang CC, Chichareon P, Wang C, Shi B, Su X, Fu G, Wu Y, Zhou X, Yuan Z, Wykrzykowska JJ, Piek JJ, Serruys PW, Onuma Y, Chen Y. Asano T, et al. Among authors: wang c. EuroIntervention. 2018 Dec 20;14(12):e1306-e1315. doi: 10.4244/EIJ-D-18-00461. EuroIntervention. 2018. PMID: 30082261 Free article. Clinical Trial.
A prospective, multicenter, randomized OCT study of early neointimal condition at first and second months after BuMA Supreme stent versus XIENCE stent implantation in high-bleeding-risk coronary artery disease patients: study protocol for a randomized controlled trial.
Li B, Jin QH, Chen YD, Wang CQ, Shi B, Su X, Fu GS, Wu YQ, Zhou XC, Yuan ZY. Li B, et al. Trials. 2019 Jun 7;20(1):335. doi: 10.1186/s13063-019-3361-0. Trials. 2019. PMID: 31174600 Free PMC article.
Association between P2Y12 inhibitor reloading and in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome already on chronic P2Y12 receptor inhibitors therapy in China: findings from the CCC-ACS (improving care for cardiovascular disease in China-acute coronary syndrome) project.
Wang Y, Geng Y, Zhang O, Xu Q, Xue Y, Zhou B, Zhang P; CCC-ACS Investigators. Wang Y, et al. Eur J Med Res. 2023 Feb 2;28(1):59. doi: 10.1186/s40001-023-01025-6. Eur J Med Res. 2023. PMID: 36732830 Free PMC article.
In-hospital outcomes of ticagrelor versus clopidogrel in patients 75 years or older with acute coronary syndrome: findings from the Improving Care for Cardiovascular Disease in China (CCC)-Acute Coronary Syndrome Project.
Yang N, Liu J, Liu J, Hao Y, Smith JSC, Huo Y, Fonarow GC, Ge J, Morgan L, Ma C, Han Y, Zhao D; Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) project investigators. Yang N, et al. Age Ageing. 2022 Nov 1;51(11):afac231. doi: 10.1093/ageing/afac231. Age Ageing. 2022. PMID: 36413586 Clinical Trial.
Association Between Platelet Glycoprotein IIb/IIIa Inhibition and In-Hospital Outcomes in ST-Elevation Myocardial Infarction Patients Treated with Coronary Thrombus Aspiration: Findings from the CCC-ACS Project.
Liu W, Li Z, Yang T, A G, Sun H, Liu H, Song X, Jin Z, Li L, Li Y, Hao Y, Liu J, Zhao D, Zhou X, Yang Q; CCC-ACS investigators. Liu W, et al. Cardiovasc Drugs Ther. 2024 Apr;38(2):315-325. doi: 10.1007/s10557-022-07398-w. Epub 2022 Nov 7. Cardiovasc Drugs Ther. 2024. PMID: 36342561
Complexity of social media in the era of generative AI.
Pan L, Wang CY, Zhou F, Lü L. Pan L, et al. Among authors: wang cy. Natl Sci Rev. 2024 Sep 19;12(1):nwae323. doi: 10.1093/nsr/nwae323. eCollection 2025 Jan. Natl Sci Rev. 2024. PMID: 39764512 Free PMC article.
109,393 results
You have reached the last available page of results. Please see the User Guide for more information.